Security key
75629V104
RECURSION PHARMACEUTICALS, INC. - COMMON STOCK (RXRX)
CUSIP: 75629V104
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 212,714,397
- Total 13F value
- $2,120,552,518
- Share change
- +6,232,465
- Put/Call ratio
- 193%
- SEC-reported price per share
- $9.97
- Number of holders
- 242
- Value change
- +$62,304,334
- Number of buys
- 152
- Number of sells
- 68
- Shares outstanding
- 525,850,455
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
242
Top holders
10
RXRX full security history
Ownership snapshot
Full 13F holder table
RECURSION PHARMACEUTICALS, INC. SEC filings
RECURSION PHARMACEUTICALS, INC. company facts
Broader feeds
Ownership snapshot
Top reported holders of RXRX - RECURSION PHARMACEUTICALS, INC. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VIKING GLOBAL INVESTORS LP
Disclosed value leader
VIKING GLOBAL INVESTORS LP
Comparable rows
15/15
Latest evidence
31 Dec 2023
13F
3/4/5
Lead comparable stake: 28%
Showing 1-6 of 15 holder rows.
Quick read
VIKING GLOBAL INVESTORS LP leads the comparable SEC ownership view at 28%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VIKING GLOBAL INVESTORS LP's linked filing trail.
Comparable ownership
Top 5
VIKING GLOBAL INVESTORS LP
28%
Anchorage Capital Group, L.L.C.
13%
SB INVESTMENT ADVISERS (UK) LTD
4.7%
Mubadala Investment Co PJSC
2.5%
Kinnevik AB (publ)
2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP |
13F
Company
|
28%
|
$241,813,863
143,085,126 shares
|
— | 31 Dec 2023 |
| Anchorage Capital Group, L.L.C. |
13F
Company
|
13%
|
$118,054,262
69,854,593 shares
|
— | 31 Dec 2023 |
| SB INVESTMENT ADVISERS (UK) LTD |
13F
Company
|
4.7%
|
$41,285,333
24,429,191 shares
|
— | 31 Dec 2023 |
| Mubadala Investment Co PJSC |
3/4/5
13F
10%+ Owner · Company
|
2.5%
from 13F
|
$137,333,970
12,985,927 shares
|
— | 02 Mar 2023 |
| Kinnevik AB (publ) |
13F
Company
|
2%
|
$102,599,886
10,405,668 shares
|
— | 31 Dec 2023 |
| MILLENNIUM MANAGEMENT LLC |
13F
Company
|
1.8%
|
$15,660,223
9,266,404 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
242
Shares
212,714,397
Rows available
242
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q1 2024 Across Filers
Q1 2024 holders
242
Q1 2024 holders
242
Holder diff
0
| Investor | Q1 2024 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q1 2024 value | Value change | Value Chg % |
|---|